Skip to main content

Advertisement

Table 4 Proportions (numbers) of males and females using cardiovascular medication (CVM) in 2008 by their cardiovascular risk scores in 1997-1999.

From: Does present use of cardiovascular medication reflect elevated cardiovascular risk scores estimated ten years ago? A population based longitudinal observational study

Risk score Males (n = 9 283) Females (n = 10 969)
  Use of CVM (%)
Framingham 60y ≥ 20% 37.1 (n = 1 533) 56.2 (n = 356)
Framingham 60y < 20% 17.1 (n = 878) 20.2 (n = 2 092)
SCORE 60y ≥ 5% 34.6 (n = 1 712) 76.1 (n = 108)
SCORE 60y < 5% 16.1 (n = 699) 21.6 (n = 2 340)
NORRISK ≥1% 40.0 (n = 1 071) 72.6 (n = 53)
NORRISK < 1% 20.3 (n = 1 340) 21.9 (n = 2 395)
BP > 150/95 mm Hg 82.7 (n = 7 677) 87.9 (n = 9 642)
Cholesterol > 8 mmol/l 58.1 (n = 5 393) 64.4 (n = 7 064)